DOCSLIB.ORG

Paterns and Trends of Amphetamine-Type Sɵmulants And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Paterns and Trends of Amphetamine-Type Sɵmulants And WĂƩĞƌŶƐĂŶĚdƌĞŶĚƐŽĨ ŵƉŚĞƚĂŵŝŶĞͲdLJƉĞ^ƟŵƵůĂŶƚƐ ĂŶĚKƚŚĞƌƌƵŐƐ ƐŝĂĂŶĚƚŚĞWĂĐŝĮĐ 'ůŽďĂů^DZdWƌŽŐƌĂŵŵĞ 2012 Printed: December 2012 Authorship: Global SMART Programme Global team: Dr. Justice Tettey, Chief, Laboratory and Scientific Section Ms. Beate Hammond, Programme Expert/Global SMART Manager East Asia team: Mr. Tun Nay Soe, Programme Coordinator Mr. Shawn Kelley, Regional ATS Analyst Ms. Porntipa Pahnichaputt, Project Assistant Mr. Akara Umapornsakula, Web Assistant Ms. Annebeth Wijtenburg, SMART Intern Disclaimer: This document has not been formally edited. The designations employed and the presentation of the material in the document does not imply the expression of any opinion on the part of the United Nations concerning the legal staus of any country, territory, city or area under its authority or concerning the delimitations of its frontiers and boundaries. Patterns and Trends of Amphetamine-Type Stimulants and 2WKHU'UXJV$VLDDQGWKH3DFL¿F 2012 A Report from the Global SMART Programme December 2012 United Nations Office on Drugs and Crime Table of Contents Acknowledgements ....................................................................................................................................i The Global SMART Programme ...............................................................................................................ii Abbreviations ...........................................................................................................................................iii List of tables and figures ..........................................................................................................................vi Notes to the reader .................................................................................................................................... x Executive Summary ...................................................................................................................................1 Background and Method ..........................................................................................................................3 Regional Trends ........................................................................................................................................5 East and South-East Asia ......................................................................................................................7 Pacific Island States and territories .....................................................................................................27 South Asia ..........................................................................................................................................31 National Trends ......................................................................................................................................35 Australia .............................................................................................................................................37 Emerging trends and concerns ............................................................................................................ 37 Overview of the drug situation ........................................................................................................... 37 Patterns and trends of drug use ........................................................................................................... 37 Injecting drug use ............................................................................................................................... 38 Drug treatment ................................................................................................................................... 38 Drug-related arrests, seizures and prices .............................................................................................. 39 Sources of illicit drugs ......................................................................................................................... 41 Forensic data ....................................................................................................................................... 42 Brunei Darussalam ............................................................................................................................43 Emerging trends and concerns ............................................................................................................ 43 Overview of the drug situation ........................................................................................................... 43 Patterns and trends of drug use ........................................................................................................... 43 Injecting drug use ............................................................................................................................... 43 Drug treatment ................................................................................................................................... 43 Drug-related arrests, seizures and prices .............................................................................................. 44 Sources of illicit drugs ......................................................................................................................... 45 Forensic data ....................................................................................................................................... 46 Cambodia ..........................................................................................................................................47 Emerging trends and concerns ............................................................................................................ 47 Overview of the drug situation ........................................................................................................... 47 Patterns and trends of drug use ........................................................................................................... 47 Injecting drug use ............................................................................................................................... 48 Drug treatment ................................................................................................................................... 48 Drug-related arrests, seizures and prices .............................................................................................. 48 Sources of illicit drugs ......................................................................................................................... 50 Forensic data ....................................................................................................................................... 50 China .................................................................................................................................................51 Emerging trends and concerns ............................................................................................................ 51 Overview of the drug situation ........................................................................................................... 51 Patterns and trends of drug use ........................................................................................................... 51 Injecting drug use ............................................................................................................................... 52 Drug treatment ................................................................................................................................... 52 Drug-related arrests, seizures and prices .............................................................................................. 53 Sources of illicit drugs ......................................................................................................................... 54 Forensic data ....................................................................................................................................... 55 Indonesia ...........................................................................................................................................59 Emerging trends and concerns ............................................................................................................ 59 Overview of the drug situation ........................................................................................................... 59 Patterns and trends of drug use ........................................................................................................... 59 Injecting drug use ............................................................................................................................... 60 Drug treatment ................................................................................................................................... 60 Drug-related arrests, seizures and prices .............................................................................................. 61 Sources of illicit drugs ......................................................................................................................... 62 Forensic data ....................................................................................................................................... 63 Japan ..................................................................................................................................................65
Load more

Recommended publications
  • Scientific Assessment of Ephedra Species (Ephedra Spp.)
    Annex 3 Ref. Ares(2010)892815 – 02/12/2010 Recognising risks – Protecting Health Federal Institute for Risk Assessment Annex 2 to 5-3539-02-5591315 Scientific assessment of Ephedra species (Ephedra spp.) Purpose of assessment The Federal Office of Consumer Protection and Food Safety (BVL), in collaboration with the ALS working party on dietary foods, nutrition and classification issues, has compiled a hit list of 10 substances, the consumption of which may pose a health risk. These plants, which include Ephedra species (Ephedra L.) and preparations made from them, contain substances with a strong pharmacological and/or psychoactive effect. The Federal Ministry of Food, Agriculture and Consumer Protection has already asked the EU Commission to start the procedure under Article 8 of Regulation (EC) No 1925/2006 for these plants and preparations, for the purpose of including them in one of the three lists in Annex III. The assessment applies to ephedra alkaloid-containing ephedra haulm. The risk assessment of the plants was carried out on the basis of the Guidance on Safety Assessment of botanicals and botanical preparations intended for use as ingredients in food supplements published by the EFSA1 and the BfR guidelines on health assessments2. Result We know that ingestion of ephedra alkaloid-containing Ephedra haulm represents a risk from medicinal use in the USA and from the fact that it has now been banned as a food supplement in the USA. Serious unwanted and sometimes life-threatening side effects are associated with the ingestion of food supplements containing ephedra alkaloids. Due to the risks described, we would recommend that ephedra alkaloid-containing Ephedra haulm be classified in List A of Annex III to Regulation (EC) No 1925/2006.
    [Show full text]
  • Buffers a Guide for the Preparation and Use of Buffers in Biological Systems Calbiochem® Buffers a Guide for the Preparation and Use of Buffers in Biological Systems
    Buffers A guide for the preparation and use of buffers in biological systems Calbiochem® Buffers A guide for the preparation and use of buffers in biological systems Chandra Mohan, Ph.D. EMD, San Diego, California © EMD, an affiliate of Merck KGaA, Darmstadt, Germany. All rights reserved. A word to our valued customers We are pleased to present to you the newest edition of Buffers: A Guide for the Preparation and Use of Buffers in Biological Systems. This practical resource has been especially revamped for use by researchers in the biological sciences. This publication is a part of our continuing commitment to provide useful product information and exceptional service to you, our customers. You will find this booklet a highly useful resource, whether you are just beginning your research work or training the newest researchers in your laboratory. Over the past several years, EMD Biosciences has clearly emerged as a world leader in providing highly innovative products for your research needs in Signal Transduction, including the areas of Cancer Biology, Alzheimer’s Disease, Diabetes, Hypertension, Inflammation, and Apoptosis. Please call us today for a free copy of our LATEST Catalog that includes tools for signal transduction and life science research. If you have used our products in the past, we thank you for your support and confidence in our products, and if you are just beginning your research career, please call us and give us the opportunity to demonstrate our exceptional customer and technical service. Corrine Fetherston Sr. Director, Marketing ii Table of Contents: Why does Calbiochem® Biochemicals Publish a Booklet on Buffers? .
    [Show full text]
  • Bankruptcy Forms
    Fill in this information to identify the case: Debtor name MBH Highland, LLC United States Bankruptcy Court for the: MIDDLE DISTRICT OF TENNESSEE Case number (if known) 3:20-bk-01940 Check if this is an amended filing Official Form 206Sum Summary of Assets and Liabilities for Non-Individuals 12/15 Part 1: Summary of Assets 1. Schedule A/B: Assets-Real and Personal Property (Official Form 206A/B) 1a. Real property: Copy line 88 from Schedule A/B............................................................................................................................. $ 0.00 1b. Total personal property: Copy line 91A from Schedule A/B......................................................................................................................... $ 5,215,549.26 1c. Total of all property: Copy line 92 from Schedule A/B........................................................................................................................... $ 5,215,549.26 Part 2: Summary of Liabilities 2. Schedule D: Creditors Who Have Claims Secured by Property (Official Form 206D) Copy the total dollar amount listed in Column A, Amount of claim, from line 3 of Schedule D.................................... $ 11,094,253.00 3. Schedule E/F: Creditors Who Have Unsecured Claims (Official Form 206E/F) 3a. Total claim amounts of priority unsecured claims: Copy the total claims from Part 1 from line 5a of Schedule E/F.......................................................................... $ 0.00 3b. Total amount of claims of nonpriority amount of unsecured
    [Show full text]
  • Incorporating Parents in the Anti-Doping Fight: a Test of the Viability of a Parent-Based Prevention Program
    1 Social Science Research Fund: Incorporating Parents in the Anti-Doping Fight: A Test of the Viability of a Parent-Based Prevention Program Final Report Submitted to: World Anti-Doping Agency Prepared by: Tonya Dodge, Ph.D. Skidmore College* *Investigator will be moving to The George Washington University Contact Information: Tonya Dodge, Ph.D. The George Washington University Department of psychology 2125 G Street, NW Washington, DC 20052 e-mail: [email protected] 2 Table of Contents Executive Summary.............................................................................................................................................. 3 Background ............................................................................................................................................................. 5 Interventions Targeting AS Use ....................................................................................................................... 6 Building Parent-Based Interventions: Considerations ........................................................................... 7 A Parent-Based Framework to Prevent AS and NS Use ......................................................................... 9 Study Aims ............................................................................................................................................................ 10 Methods ................................................................................................................................................................
    [Show full text]
  • Fall TNP Herbals.Pptx
    8/18/14 Introduc?on to Objecves Herbal Medicine ● Discuss history and role of psychedelic herbs Part II: Psychedelics, in medicine and illness. Legal Highs, and ● List herbs used as emerging legal and illicit Herbal Poisons drugs of abuse. ● Associate main plant and fungal families with Jason Schoneman RN, MS, AGCNS-BC representave poisonous compounds. The University of Texas at Aus?n ● Discuss clinical management of main toxic Schultes et al., 1992 compounds. Psychedelics Sacraments: spiritual tools or sacred medicine by non-Western cultures vs. Dangerous drugs of abuse vs. Research and clinical tools for mental and physical http://waynesword.palomar.edu/ww0703.htm disorders History History ● Shamanic divinaon ○ S;mulus for spirituality/religion http://orderofthesacredspiral.blogspot.com/2012/06/t- mckenna-on-psilocybin.html http://www.cosmicelk.net/Chukchidirections.htm 1 8/18/14 History History http://www.10zenmonkeys.com/2007/01/10/hallucinogenic- weapons-the-other-chemical-warfare/ http://rebloggy.com/post/love-music-hippie-psychedelic- woodstock http://fineartamerica.com/featured/misterio-profundo-pablo- amaringo.html History ● Psychotherapy ○ 20th century: un;l 1971 ● Recreaonal ○ S;mulus of U.S. cultural revolu;on http://qsciences.digi-info-broker.com http://www.uspharmacist.com/content/d/feature/c/38031/ http://en.wikipedia.org/nervous_system 2 8/18/14 Main Groups Main Groups Tryptamines LSD, Psilocybin, DMT, Ibogaine Other Ayahuasca, Fly agaric Phenethylamines MDMA, Mescaline, Myristicin Pseudo-hallucinogen Cannabis Dissociative
    [Show full text]
  • Biological Buffers and Ultra Pure Reagents
    Biological Buffers and Ultra Pure Reagents Are MP Buffers in your corner? One Call. One Source. A World of Ultra Pure Biochemicals. www.mpbio.com Theoretical Considerations Since buffers are essential for controlling the pH in many Since, under equilibrium conditions, the rates of dissociation and biological and biochemical reactions, it is important to have a association must be equal, they may be expressed as: basic understanding of how buffers control the hydrogen ion concentration. Although a lengthy, detailed discussion is impractical, + - k1 (HAc) = k2 (H ) (Ac ) some explanation of the buffering phenomena is important. Or Let us begin with a discussion of the equilibrium constant (K) for + - weak acids and bases. Acids and bases which do not completely k1 = (H ) (Ac ) dissociate in solution, but instead exist as an equilibrium mixture of k (HAc) undissociated and dissociated species, are termed weak acids and 2 bases. The most common example of a weak acid is acetic acid. If we now let k1/k2 = Ka , the equilibrium constant, the equilibrium In solution, acetic acid exists as an equilibrium mixture of acetate expression becomes: ions, hydrogen ions, and undissociated acetic acid. The equilibrium between these species may be expressed as follows: + - Ka = (H ) (Ac ) k1 (HAc) + - HAc ⇌ H + Ac which may be rearranged to express the hydrogen ion concentration k2 in terms of the equilibrium constant and the concentrations of undissociated acetic acid and acetate ions as follows: where k1 is the dissociation rate constant of acetic acid to acetate and hydrogen ions and k is the association rate constant of the ion 2 (H+) = K (HAc) species to form acetic acid.
    [Show full text]
  • Chemical Mechanical Planarization for Tungsten-Containing Substrates
    (19) TZZ _ T (11) EP 2 779 217 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 17.09.2014 Bulletin 2014/38 H01L 21/321 (2006.01) C09G 1/02 (2006.01) (21) Application number: 14158825.1 (22) Date of filing: 11.03.2014 (84) Designated Contracting States: • Zhou, Hongjun AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Chandler, AZ Arizona 85248 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • Lew, Blake J. PL PT RO RS SE SI SK SM TR Scottsdale, AZ Arizona 85251 (US) Designated Extension States: • Schlueter, James Allen BA ME Phoenix, AZ Arizona 85045 (US) •Schwartz,Jo- Ann Theresa (30) Priority: 12.03.2013 US 201361777165 P Fountain Hills, AZ Arizona 85268 (US) 27.12.2013 US 201314142087 (74) Representative: Beck Greener (71) Applicant: AIR PRODUCTS AND CHEMICALS, INC. Fulwood House Allentown, PA 18195-1501 (US) 12 Fulwood Place London WC1V 6HR (GB) (72) Inventors: • Shi, Xiaobo Chandler, AZ Arizona 85224 (US) (54) Chemical mechanical planarization for tungsten-containing substrates (57) Chemical mechanical polishing (CMP) compo- of piperazine derivatives, salts of cyanate, and combina- sitions for polishing tungsten or tungsten- containing sub- tions thereof; and a liquid carrier. Systems and processes strates comprise an abrasive, at least one solid catalyst, use the aqueous formulations for polishing tungsten or a chemical additive selected from the groups consisting tungsten-containing substrates. EP 2 779 217 A2 Printed by Jouve, 75001 PARIS (FR) EP 2 779 217 A2 Description BACKGROUND OF THE INVENTION 5 [0001] This invention relates generally to the chemical-mechanical planarization (CMP) of tungsten-containing sub- strates on semiconductor wafers.
    [Show full text]
  • Dietary Supplements Containing Ephedrine Alkaloids
    SUMMARY OF DATA FOR CHEMICAL SELECTION Dietary Supplements Containing Ephedrine Alkaloids BASIS OF NOMINATION Dietary supplements containing ephedrine alkaloids from herbal sources (ephedra) are brought to the attention of the CSWG as part of an ongoing National Institutes of Health (NIH) Office of Dietary Supplements (ODS) research initiative on the safety and efficacy of these products. This initiative was recommended by the Senate Committee on Appropriations in fiscal year (FY) 2001. In its Report making FY 2002 appropriations for the Department of Health and Human Services, the Committee expressed pleasure that the ODS followed through on its FY 2001 recommendation and urged the ODS to continue and expand this important effort. The nomination of ephedra­ containing supplements to the National Toxicology Program (NTP) is part of the expanded effort by the ODS. As the Senate Committee noted, the number of Americans taking dietary supplements containing ephedra has risen dramatically. Dietary supplements containing herbal ephedra (chiefly Ephedra sinica Stapf.) are widely used as diet aids and athletic performance enhancers, with over 3 billion servings1 sold each year for weight loss alone. The active ingredients in these supplements are primarily ephedrine and pseudoephedrine with small amounts of other ephedrine alkaloids usually present. Ephedra-based diet aids often contain other stimulants, such as caffeine (guarana), as well as salicin, diuretics, and cathartics. Ephedra-containing performance enhancers often contain caffeine and other ingredients, such as chromium picolinate or l-carnitine, and may be consumed with other performance enhancers, such as androstenedione and creatine monohydrate. The ephedrine alkaloids are sympathomimetic amines, a class of compounds with fairly well characterized short to medium term biological activities.
    [Show full text]
  • Ephedra and Energy Drinks on College Campuses by Daniel Ari Kapner
    INFOFACTSRESOURCES The Higher Education Center for Alcohol and Other Drug Abuse and Violence Prevention Ephedra and Energy Drinks on College Campuses by Daniel Ari Kapner The February 2003 death of Baltimore Orioles pitcher levels . alertness and perception.”6,7 Also known found. Half of the events in which ephedra was the Steve Bechler, who according to the coroner’s report as ma huang, ephedra is considered a “natural” main contributing factor affected apparently healthy died after taking ephedrine alkaloids (ephedra), has supplement7 and Chinese herbalists have used the people under age 30.13 garnered national attention for the topic of nutri- herb Ephedra for thousands of years to treat asthma The Annals of Internal Medicine published a study tional supplements and energy drinks.1 While the and colds.8 Ephedra has been used in some over-the- in 2003 suggesting that ephedra accounted for 64 headlines have focused mainly on use by professional counter cold and asthma products in the United States.9 percent of all adverse reactions from herbal products athletes, these substances have gained popularity Until recently, ephedra was found in many weight- in 2001, even though it represented only 4.3 percent of among college-age students and are associated with loss and energy-enhancing products. Popular supple- industry sales in that year.14,15 the deaths of Florida State University linebacker ments that contained ephedra included Metabolife A study published in the New England Journal Devaughn Darling, Northwestern University football and Ripped Fuel, both of which are now available in of Medicine in 2000 examined 140 cases of ephedra- player Rashid Wheeler, and the University at Albany, ephedra-free formulations.
    [Show full text]
  • Chapter 1.Litho
    exploited by drug trafficking organizations. What is more, the rise in drug abuse in such countries has proven extremely difficult to contain because of INTRODUCTION fragmented and unprepared medical and health authorities. In situations of armed conflict, illicit Governments and international organizations drug revenues – or the drugs themselves – are regularly collect and analyze data on illicit drug regularly exchanged for arms. production, trafficking and consumption. In most cases, however, trends can be identified only indi- In a world that becomes increasingly complex, the rectly due to the inherently clandestine nature of scope for profit-making in the illicit drug trade is the activities. With this constraint acknowledged at rapidly expanding. The relationship between illicit the outset, this chapter seeks to describe global drugs and economic development, for example, is trends on the basis of available information. The far more important than generally recognized: overview may help to place in context trends and while it is widely accepted that illicit cultivation issues described in subsequent parts of this report. occurs in many developing countries, the effects of the illegal trade on local communities is all too The illicit drug phenomenon cannot be viewed often assumed to be cost-free. In fact, the spillover outside the context of contemporary economic, of production into abuse has a negative impact on social and political developments. Changes in the the local workforce. Illicit sector income is unevenly world political economy and advances in distributed; at the lower level of the production technology over the past three decades have had a chain it barely exceeds income in the licit sector.
    [Show full text]
  • 2016 Conference Showguide
    Mental Health over the Life Span Scientific Conference and Annual General Meeting March 17–20 2016 The Rimrock Resort Hotel Banff, Alberta WELCOME TO THE 2O16 APA SCIENTIFIC CONFERENCE The Alberta Psychiatric Association (APA) is the not-for-profit professional organization that represents the psychiatrists of Alberta. CONFERENCE LEARNING OBJECTIVES The APA has stood for more than fifty years as an advocate for its psychiatrist members, providing leadership and support for their role in the provision of quality mental health care in Alberta by promoting 1. To examine, consider and appraise current effective professional relationships and influencing health policy and and leading clinical practices to enhance clinical practice. patient care. The APA has close ties to the Canadian Psychiatric Association and its committee structure mirrors that of the federal body addressing science and research, psychiatric education, standards of practice and 2. To explore mental health issues during economics. all life cycles and how it has evolved over The APA allies with the Alberta Medical Association sharing executive time. membership with the Sections of General Psychiatry and Child and Adolescent Psychiatry, through which it elects members to the Representative Forum and works to achieve equitable fees and 3. To discuss and bring more awareness to schedule of medical benefits. mental health issues in children and the This event is an accredited group learning activity (section 1) as elderly. defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by the Canadian Psychiatric Association (CPA). The specific opinions and content of this event are not necessarily those of the CPA, and are the responsibility of the organizer(s) alone.
    [Show full text]
  • Methamphetamine Use: Lessons Learned
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Methamphetamine Use: Lessons Learned Author(s): Dana Hunt, Ph.D.; Sarah Kuck; Linda Truitt, Ph.D. Document No.: 209730 Date Received: February 2006 Award Number: 99-C-008 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. ANALYTIC SUPPORT PROGRAM CONTRACT TASK REQUIREMENT T-043: Methamphetamine Use: Lessons Learned Contract No. 99-C-008 Cambridge, MA Lexington, MA Hadley, MA Bethesda, MD Chicago, IL January 31, 2006 Prepared for Raymond C. German Contracting Officer Christine Crossland Senior Social Science Analyst National Institute of Justice Office of Justice Programs Acquisition Management Division 810 Seventh Street, SW Washington, D.C. 20001 Prepared by Dana Hunt, Ph.D. Sarah Kuck Abt Associates Inc. Linda Truitt, Ph.D. 55 Wheeler Street Cambridge, MA 02138 Contents Executive Summary...............................................................................................................iii History of Methamphetamine Use .................................................................................iii Trends.............................................................................................................................iii
    [Show full text]